Jan 04 2022: This sample was re-analyzed and BZO-CHMOXIZID has been confirmed.
Oct 25 2021: Through DrugsData's expert network, we got a tentative identification of BZO-CHMOXIZID [CAS# 1048973-67-6], a modified MDA 19 [CAS# 1048973-47-2], for the substance that was originally unidentified. Reference standards for BZO-CHMOXIZID and MDA 19 have been ordered, and the sample will be re-analyzed after the reference standards reach the lab. These are cannabinoid receptor agonists.
Send in a sample for testing
DrugsData tests all psychoactive drugs including ecstasy tablets, powders, research chemicals, novel pschoactive substances, and other drugs through our DEA-licensed laboratory. Ecstasy/Molly tablets cost $100. Recreational drug powder/crystal/blotter costs $100. Pharmaceuticals, supplements and all others cost $150 per analysis.
Should the public have access to independent analysis of the products they consume?
The vast majority of analyses of over-the-counter, prescription, and recreational drugs are performed in secret with no independent oversite or review. No other historical record, free from politically-controlled agencies, is currently available in North America nor most other parts of the world.
DrugsData, a project of Erowid Center, needs the support of professionals, students, parents, individuals with means, and small foundations for a total yearly budget of around $120,000 USD. Erowid Center's general budget and the co-pays we require fund most of this cost.
Oct 25 2021: Through DrugsData's expert network, we got a tentative identification of BZO-CHMOXIZID [CAS# 1048973-67-6], a modified MDA 19 [CAS# 1048973-47-2], for the substance that was originally unidentified. Reference standards for BZO-CHMOXIZID and MDA 19 have been ordered, and the sample will be re-analyzed after the reference standards reach the lab. These are cannabinoid receptor agonists.